drugset / Trial / NCT01969890

STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial

NCT01969890 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to demonstrate that granulocyte colony-stimulating factor (G-CSF) therapy in addition to state-of-the-art treatment (pharmacological and non pharmacological) is safe and significantly improves clinical outcome in patients with reduced left ventricular ejection fraction (LVEF) (≤45%) after successful reperfusion for large anterior acute myocardial infarction.

Timeline

Start
2013-10
Primary completion
2018-05
Completion
2018-05

Outcome

Missed primary endpoint

Stopped (Enrollment): “Upon DSMC suggestion due to a too low enrollment rate.”

paper No difference was found in the composite primary outcome between study groups (HR 1.20; 95% CI 0.63 to 2.28). PMID 39401872 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject G-CSF Protein / enzyme biologic 5 ug/kg Subcutaneous